13127-18-9
13127-18-9 structure
- Name: Erythromycin A Oxime
- Chemical Name: Erythromycin A Oxime
- CAS Number: 13127-18-9
- Molecular Formula: C37H68N2O13
- Molecular Weight: 748.941
- Create Date: 2018-10-02 22:16:46
- Modify Date: 2026-07-02 23:00:34
| Name | Erythromycin A Oxime |
|---|---|
| Synonyms |
9-Hydroxyimino-9-deoxoerythromycin A
9-(Hydroxyimino)-9-deoxoerythromycin Clithromycin Impurity J Erythromycin A Oxime (Roxithromycin Impurity C) Roxithromycin Impurity C(Clithromycin Impurity J) lithromycin Impurity J ERYTHROMYCIN-9-OXIME Azithromycin Impurity S (9-Erythromycin A Oxime/ Erythromycin Oxime/ Roxithromycin Impurity C/ Clithromycin Impurity J) 9-O-Erythromycin oxime ERYTHROMYCIN A 9-OXIME ERYTHROMYCIN A 9-OXIME (E) RoxithroMycin IMpurity C Erythromycin A Oxime (Clithromycin Impurity J) (3R,4S,5S,6R,7R,9R,10E,11S,12R,13S,14R)-6-{[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-14-ethyl-7,12,13-trihydroxy-4-{[(2R,4R,5S,6S)-5-hydro (3R,4S,5S,6R,7R,9R,11S,12R,13S,14R)-6-(((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-14-ethyl-7,12,13-trihydroxy-4-(((2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl)oxy)-10-(hydroxyimino)-3,5,7,9,11,13-hexamethyl-oxacyclotetradecan-2-one Azithromycin Impurity 19 Clithromycin Impurity J (Roxithromycin Impurity C/ Erythromycin Oxime/ Azithromycin Impurity S/ 9-Erythromycin A Oxime) ERYTHROMYCIN OXIME Erythromycin Oxime (Azithromycin Impurity S/ 9-Erythromycin A Oxime/ Roxithromycin Impurity C/ Clithromycin Impurity J) UNII-10W452CMTZ Erythromycin A (E)-9-oxime (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-4-((2,6-didesoxy-3-C-methyl-3-O-methyl-α-L-ribo-hexopiranosyl)oxy)-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-6-((3,4,6-tridesoxy-3-dimethylamino-β-.sc.d.sc.-xylohexapiranosyl)oxy)oxacyclotetradecan-2-ona-10-oxime (E) Erythromycin A 9-Oxime (Mixture of Z and E Isomers) 9-Hydroxyimino-9-deoxoerythromycin Roxithromycin Impurity CQ: What is Roxithromycin Impurity C Q: What is the CAS Number of Roxithromycin Impurity C Q: What is the storage condition of Roxithromycin Impurity C Q: What e the applications of Roxithromycin Impurity C (3R,4S,5S,6R,7R,9R,10E,11S,12R,13S,14R)-6-{[(2S,3R,4S,6R)-4-(Dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-14-ethyl-7,12,13-trihydroxy-10-(hydroxyimino)-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-3,5,7,9,11,13-hexamethyloxacyclotetradecan-2-one Clithromycin Impurity J/Erythromycin oxime/Erythromycin A 9-Oxime (Mixture of Z and E Isomers)/(3R,4S,5S,6R,7R,9R,11S,12R,13S,14R)-6-{[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy}-14-ethyl-7,12,13-trihydroxy-4-{[(2R,4R,5S,6S)-5-hy Roxithromycin Impurity C (Erythromycin Oxime/ Azithromycin Impurity S/ 9-Erythromycin A Oxime/ Clithromycin Impurity J) (3R,4S,5S,6R,7R,9R,10E,11S,12R,13S,14R)-6-{[(2S,3R,4S,6R)-4-(DIMETHYLAMINO)-3-HYDROXY-6-METHYLOXAN-2 HSDB-3074 Clarithromycin EP Impurity J 9-ErythroMycin 9-OxiMe CETH-001 erythromycin oxime (3R,4S,5S,6R,7R,9R,11S,12R,13S,14R,E)-6-(((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-14-ethyl-7,12,13-trihydroxy-4-(((2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethy ERYTHERYTHROMYCIN OXIMEROMYCIN OXIME (3R,4S,5S,6R,7R,9R,12R,13S,14R)-6-{[(2R,3R,4S,6R)-4-(Dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-14-ethyl-7,12,13-trihydroxy-10-(hydroxyimino)-4-{[(2S,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-3,5,7,9,11,13-hexamethyloxacyclotetradecan-2-one Erythromycin A 9-Oxime/Clithromycin Impurity J Erythromycin oxyme RU-28111 9-ErythroMycin A OxiMe (3R,4S,5S,6R,7R,9R,11S,12R,13S,14R,E)-14-ethyl-12,13-dihydroxy-4-(((2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl)oxy)-6-(((2S,3R,4S,6R)-3-hydroxy-6-methyl-4-(methylamino)tetra Clithromycin Impurity 2(Clithromycin Impurity J) Erythromycin A 9-Oxime (Mixture of Z and E Isomers)/Erythromycin oxime/Clithromycin Impurity J/(3R,4S,5S,6R,7R,9R,11S,12R,13S,14R)-6-{[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy}-14-ethyl-7,12,13-trihydroxy-4-{[(2R,4R,5S,6S)-5-hy HSDB3074 |
| Density | 1.3±0.1 g/cm3 |
|---|---|
| Boiling Point | 841.0±65.0 °C at 760 mmHg |
| Molecular Formula | C37H68N2O13 |
| Molecular Weight | 748.941 |
| Flash Point | 462.4±34.3 °C |
| Exact Mass | 748.472168 |
| PSA | 209.43000 |
| LogP | 3.04 |
| Vapour Pressure | 0.0±0.6 mmHg at 25°C |
| Index of Refraction | 1.553 |
|
~94%
13127-18-9 |
| Literature: Chen, Mingwei; Muri, Estela M. F.; Jacob, Melissa; Williamson, John S. Medicinal Chemistry Research, 2003 , vol. 12, # 3 p. 111 - 129 |
|
~%
13127-18-9 |
| Literature: Magnetic Resonance in Chemistry, , vol. 39, # 6 p. 355 - 360 |
| Precursor 1 | |
|---|---|
| DownStream 2 | |
